Drug Development and Industrial Pharmacy

Papers
(The H4-Index of Drug Development and Industrial Pharmacy is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
In vivo behavior of technetium-99m labeled ibuprofen in infection and inflamation animal models53
Establishing virtual bioequivalence and bio-related dissolution specifications for naproxen using physiologically based pharmacokinetic modeling and in vitro biorelevant45
Development and characterization of 3D printed ethylene vinyl acetate (EVA) as drug delivery device for the treatment of overactive bladder31
Microneedle-assisted transdermal delivery of amlodipine besylate loaded nanoparticles26
Preparation and evaluation of liposome with ropivacaine ion-pairing in local pain management24
Formulation, biopharmaceutical evaluation and in-vitro screening of polyherbal phytosomes for breast cancer therapy23
A QbD approach for optimizing the lyophilization parameters of cyclophosphamide monohydrate20
Assessing the viability of carbamoylethyl pullulan-g-stearic acid based smart polymeric micelles for tumor targeting of raloxifene19
Radioprotective effect of nanoniosome loaded by Mentha Pulegium essential oil on human peripheral blood mononuclear cells exposed to ionizing radiation18
Improving cellular uptake and synergetic anti-tumor effects of magnolol and Brucea javanica oil through self-microemulsion15
Studies on ameliorative potentials of quercetin nanoparticles against imidacloprid induced subacute genotoxicity and histopathological alteration in Swiss albino mice15
Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model14
Synthesis of novel combinatorial drug delivery system (nCDDS) for co-delivery of 5-fluorouracil and leucovorin calcium for colon targeting and controlled drug release14
Ginkgolic acid as a fusion inhibitor: targeting RBD-ACE2 interaction with in silico, in vitro evidence of allosteric modulation and potent virucidal effect13
Transferrin functionalized poloxamer-chitosan nanoparticles of metformin: physicochemical characterization, in-vitro, and Ex-vivo studies13
Use of nanoemulsion for co-delivery of silibinin and cabazitaxel for prostate cancer treatment13
An overview of COVID-19 aerosol box for preventing droplet and aerosol contaminations in healthcare providers performing airway intubation13
Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: in-vitro and in-vivo evaluation13
Solubility-permeability interplay of hydrotropic solubilization of piroxicam13
Polymyxin B and silver nanoparticles: a nanotechnology-driven approach to overcome antibiotic resistance13
0.25490713119507